BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19843644)

  • 1. Loss of imprinting of the insulin-like growth factor II (IGF2) gene in esophageal normal and adenocarcinoma tissues.
    Zhao R; DeCoteau JF; Geyer CR; Gao M; Cui H; Casson AG
    Carcinogenesis; 2009 Dec; 30(12):2117-22. PubMed ID: 19843644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF2 DMR0 methylation, loss of imprinting, and patient prognosis in esophageal squamous cell carcinoma.
    Murata A; Baba Y; Watanabe M; Shigaki H; Miyake K; Ishimoto T; Iwatsuki M; Iwagami S; Yoshida N; Oki E; Morita M; Nakao M; Baba H
    Ann Surg Oncol; 2014 Apr; 21(4):1166-74. PubMed ID: 24318096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of imprinting and abnormal expression of the insulin-like growth factor 2 gene in gastric cancer.
    Zuo QS; Yan R; Feng DX; Zhao R; Chen C; Jiang YM; Cruz-Correa M; Casson AG; Kang XD; Han F; Chen T
    Mol Carcinog; 2011 May; 50(5):390-6. PubMed ID: 21268128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LOI of IGF2 is associated with esophageal cancer and linked to methylation status of IGF2 DMR.
    Xu W; Fan H; He X; Zhang J; Xie W
    J Exp Clin Cancer Res; 2006 Dec; 25(4):543-7. PubMed ID: 17310846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor.
    Ravenel JD; Broman KW; Perlman EJ; Niemitz EL; Jayawardena TM; Bell DW; Haber DA; Uejima H; Feinberg AP
    J Natl Cancer Inst; 2001 Nov; 93(22):1698-703. PubMed ID: 11717330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H19 DMR methylation correlates to the progression of esophageal squamous cell carcinoma through IGF2 imprinting pathway.
    Gao T; He B; Pan Y; Gu L; Chen L; Nie Z; Xu Y; Li R; Wang S
    Clin Transl Oncol; 2014 Apr; 16(4):410-7. PubMed ID: 23943562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of imprinting of the insulin-like growth factor II gene in renal cell carcinoma.
    Nonomura N; Nishimura K; Miki T; Kanno N; Kojima Y; Yokoyama M; Okuyama A
    Cancer Res; 1997 Jul; 57(13):2575-7. PubMed ID: 9205056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relaxation of insulin-like growth factor 2 gene imprinting in esophageal cancer.
    Mori M; Inoue H; Shiraishi T; Mimori K; Shibuta K; Nakashima H; Mafune K; Tanaka Y; Ueo H; Barnard GF; Sugimachi K; Akiyoshi T
    Int J Cancer; 1996 Nov; 68(4):441-6. PubMed ID: 8945613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The expression and imprinting status of insulin-like growth factor 2 gene in colorectal cancer].
    Zhang FR; He XB; Yang YH; Xie W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):31-4. PubMed ID: 12579496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-2 (IGF2) loss of imprinting marks a field defect within human prostates containing cancer.
    Bhusari S; Yang B; Kueck J; Huang W; Jarrard DF
    Prostate; 2011 Nov; 71(15):1621-30. PubMed ID: 21432864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor II in uterine smooth-muscle tumors: maintenance of genomic imprinting in leiomyomata and loss of imprinting in leiomyosarcomata.
    Vu TH; Yballe C; Boonyanit S; Hoffman AR
    J Clin Endocrinol Metab; 1995 May; 80(5):1670-6. PubMed ID: 7745016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in the promoter-specific imprinting of the insulin-like growth factor-II gene in Wilms' tumor.
    Vu TH; Hoffman A
    J Biol Chem; 1996 Apr; 271(15):9014-23. PubMed ID: 8621549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors.
    Bjornsson HT; Brown LJ; Fallin MD; Rongione MA; Bibikova M; Wickham E; Fan JB; Feinberg AP
    J Natl Cancer Inst; 2007 Aug; 99(16):1270-3. PubMed ID: 17686827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of genomic imprinting of insulin-like growth factor 2 in colorectal cancer.
    Takano Y; Shiota G; Kawasaki H
    Oncology; 2000 Sep; 59(3):210-6. PubMed ID: 11053988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imprinting and expression of insulin-like growth factor-II and H19 in normal breast tissue and breast tumor.
    Yballe CM; Vu TH; Hoffman AR
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1607-12. PubMed ID: 8636375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal stability and age-related prevalence of loss of imprinting of the insulin-like growth factor-2 gene.
    Cruz-Correa M; Zhao R; Oviedo M; Bernabe RD; Lacourt M; Cardona A; Lopez-Enriquez R; Wexner S; Cuffari C; Hylind L; Platz E; Cui H; Feinberg AP; Giardiello FM
    Epigenetics; 2009 Feb; 4(2):114-8. PubMed ID: 19242102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting.
    Li X; Adam G; Cui H; Sandstedt B; Ohlsson R; Ekström TJ
    Oncogene; 1995 Jul; 11(2):221-9. PubMed ID: 7624139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF2 but not H19 shows loss of imprinting in human glioma.
    Uyeno S; Aoki Y; Nata M; Sagisaka K; Kayama T; Yoshimoto T; Ono T
    Cancer Res; 1996 Dec; 56(23):5356-9. PubMed ID: 8968084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological characteristics of colorectal cancers with loss of imprinting of insulin-like growth factor 2.
    Sasaki J; Konishi F; Kawamura YJ; Kai T; Takata O; Tsukamoto T
    Int J Cancer; 2006 Jul; 119(1):80-3. PubMed ID: 16432831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of imprinting of insulin-like growth factor 2 is associated with increased risk of primary lung cancer in the central China region.
    Zhang M; Wu CH; Zhu XL; Wang YJ
    Asian Pac J Cancer Prev; 2014; 15(18):7799-803. PubMed ID: 25292066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.